Independent Financial Information Made Easy
The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.
Open: 262.1 Close: 261.46 Change: -0.64
This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, cancer, stock, Intuit, Amgens, patient, data, and the …
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..
Amgen Inc. per Employee $1.045M P/E Ratio 17.63 EPS $14.63 Yield 3.26% Dividend $2.13 Ex-Dividend date Aug 17, 2023. Intuit stock (NASDAQ NDAQ : INTU) is a better pick than Amgen stock.
Amgen Inc. per Employee $1.045M P/E Ratio 17.63 EPS $14.63 Yield 3.26% Dividend $2.13 Ex-Dividend date Aug 17, 2023. Amgen and Horizon Therapeutics have entered into a consent order agreement with the Federal Trade Commission that resolves the pending FTC administrative lawsuit. FTC temporarily suspended its challenge to the multi-billion dollar merger between the two companies. Amgen is proud to recognize Arleen Paulino, SVP of Manufacturing, for her many contributions. Amgen stock dips after fda reveals concerns about lumakras study (amgn) Amgen: Not an investment mistake, But It Was Better Before. Federal Circuit upheld the invalidity finding by the lower court in Amgen v. Genentech ( 2022-1461) The Federal Circuit has applied the Supreme Courts reasoning since the Amgen. Intuit stock (NASDAQ NDAQ : INTU), a financial software company, is a better pick than Amgen stock. Intuit revenue growth has been better, with a 23.6% average annual growth rate in the last three years, compared to Amgen. Amgen stock trades at 5.4x trailing revenues vs. a -1% expected return for Amgen, based on Trefis Machine Learning analysis – Amgen vs. Intuit. Intuit trades at 10.2x revenues, compared to its last five-year average of 12x. Amgen, a biotechnology pioneer, discovers, develops and delivers innovative human therapeutics. The U.S. Supreme Court on Friday agreed to review Section 112 of the Patent Act for the second time in the history, accepting Amgens request to consider how much a patent must disclose in order to meet enablement requirements. Amgen has been named to the Great Place To Work® (GPTW) 2023 Europe list. Amgen Europe has been serving millions of patients in the fight against serious illnesses such as cancer, cardiovascular disease, osteoporosis, asthma, rheumatoid arthritis. Amgens late-stage data for lung cancer drug not adequate - FDA staff. U.S. Food and Drug Administration staff reviewers said on Tuesday Amgens late stage study might not be sufficient to confirm effectiveness for its lung cancer treatment. Amgen performed very effectively in 2022, reaching roughly 10 million patients around the world with our approved medicines, advancing many promising new medicines, delivering strong financial performance. Amgen strives to serve patients by transforming the promise of science and biotechnology. Amgens late-stage data for lung cancer drug not adequate - FDA staff. FDA staff said on Tuesday that data might not be sufficient to confirm effectiveness. Amgen is now accepting applications through Nov. 2, 2021. Do you know of a promising start-up in the SoCal area? Apply below! Amgen announced the first and only targeted treatment specifically designed for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer. The horrific murder of George Floyd in May 2020 served as a catalyst for many companies – Amgen included – to redouble their efforts to build a more just and equitable society. Amgen employees have given back in numerous ways to the communities where they live and work during the last few months. Listen to the full podcast here: https:// bit.ly/3c9uedX. Amgen is an ally and will continue to fight for equal justice and equal opportunity for all. Amgen presents data for migraine treatment reinforcing long-term efficacy and safety.
"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."
How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, cancer, stock, Intuit, Amgens, patient, data, and the most common words in the summary are: amgen, stock, science, overview, job, market, pdf, . One of the sentences in the summary was: per Employee $1.045M P/E Ratio 17.63 EPS $14.63 Yield 3.26% Dividend $2.13 Ex-Dividend date Aug 17, 2023. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #science #overview #job #market #pdf.
Read more →Open: 276.84 Close: 273.17 Change: -3.67
Read more →Open: 272.81 Close: 273.75 Change: 0.94
Read more →Open: 279.1 Close: 278.49 Change: -0.61
Read more →Open: 283.85 Close: 283.51 Change: -0.34
Read more →Open: 287.71 Close: 283.7 Change: -4.01
Read more →Open: 323.64 Close: 323.19 Change: -0.45
Read more →Open: 323.64 Close: 323.11 Change: -0.53
Read more →Open: 310.57 Close: 311.77 Change: 1.2
Read more →Open: 304.73 Close: 307.81 Change: 3.08
Read more →Open: 305.24 Close: 306.51 Change: 1.27
Read more →Open: 308.02 Close: 307.61 Change: -0.41
Read more →Open: 280.0 Close: 284.16 Change: 4.16
Read more →Open: 277.83 Close: 275.18 Change: -2.65
Read more →Open: 276.27 Close: 275.45 Change: -0.82
Read more →Open: 271.17 Close: 269.12 Change: -2.05
Read more →Open: 269.96 Close: 272.45 Change: 2.49
Read more →Open: 267.71 Close: 269.64 Change: 1.93
Read more →Open: 264.79 Close: 264.59 Change: -0.2
Read more →Open: 269.41 Close: 265.39 Change: -4.02
Read more →Open: 268.52 Close: 269.86 Change: 1.34
Read more →Open: 265.0 Close: 263.19 Change: -1.81
Read more →Open: 282.09 Close: 280.6 Change: -1.49
Read more →Open: 263.15 Close: 267.47 Change: 4.32
Read more →Open: 262.1 Close: 261.46 Change: -0.64
Read more →Open: 272.07 Close: 269.86 Change: -2.21
Read more →Open: 255.75 Close: 259.43 Change: 3.68
Read more →Open: 256.71 Close: 254.01 Change: -2.7
Read more →Open: 258.68 Close: 256.71 Change: -1.97
Read more →Open: 256.96 Close: 256.04 Change: -0.92
Read more →Open: 266.33 Close: 265.02 Change: -1.31
Read more →Open: 261.54 Close: 262.06 Change: 0.52
Read more →Open: 237.91 Close: 243.28 Change: 5.37
Read more →Open: 233.77 Close: 234.82 Change: 1.05
Read more →Open: 227.84 Close: 227.43 Change: -0.41
Read more →Open: 221.21 Close: 225.01 Change: 3.8
Read more →Open: 229.87 Close: 227.11 Change: -2.76
Read more →Open: 227.31 Close: 229.18 Change: 1.87
Read more →Open: 219.34 Close: 218.76 Change: -0.58
Read more →Open: 219.67 Close: 222.1 Change: 2.43
Read more →Open: 215.96 Close: 216.93 Change: 0.97
Read more →Open: 224.21 Close: 224.44 Change: 0.23
Read more →Open: 224.85 Close: 223.99 Change: -0.86
Read more →Open: 224.44 Close: 223.42 Change: -1.02
Read more →Open: 224.75 Close: 222.61 Change: -2.14
Read more →Open: 234.89 Close: 234.11 Change: -0.78
Read more →Open: 236.82 Close: 239.74 Change: 2.92
Read more →Open: 276.85 Close: 277.93 Change: 1.08
Read more →Open: 276.3 Close: 272.86 Change: -3.44
Read more →Open: 284.84 Close: 283.46 Change: -1.38
Read more →Open: 287.71 Close: 283.7 Change: -4.01
Read more →Open: 287.88 Close: 285.88 Change: -2.01
Read more →Open: 323.64 Close: 323.19 Change: -0.45
Read more →Open: 314.5 Close: 324.56 Change: 10.06
Read more →Open: 304.73 Close: 307.81 Change: 3.08
Read more →Open: 304.73 Close: 307.81 Change: 3.08
Read more →Open: 305.24 Close: 306.51 Change: 1.27
Read more →Open: 284.5 Close: 286.53 Change: 2.03
Read more →Open: 280.0 Close: 284.16 Change: 4.16
Read more →Open: 276.27 Close: 276.17 Change: -0.1
Read more →Open: 271.17 Close: 269.12 Change: -2.05
Read more →Open: 271.87 Close: 270.87 Change: -1.0
Read more →Open: 269.96 Close: 272.45 Change: 2.49
Read more →Open: 264.74 Close: 266.6 Change: 1.86
Read more →Open: 265.34 Close: 262.82 Change: -2.52
Read more →Open: 269.41 Close: 265.39 Change: -4.02
Read more →Open: 263.3 Close: 265.12 Change: 1.83
Read more →Open: 268.95 Close: 261.57 Change: -7.38
Read more →Open: 274.86 Close: 283.6 Change: 8.74
Read more →Open: 263.15 Close: 266.09 Change: 2.94
Read more →Open: 267.67 Close: 267.7 Change: 0.03
Read more →Open: 265.0 Close: 271.46 Change: 6.46
Read more →Open: 255.75 Close: 259.43 Change: 3.68
Read more →Open: 258.68 Close: 256.71 Change: -1.97
Read more →Open: 258.68 Close: 256.71 Change: -1.97
Read more →Open: 266.33 Close: 265.02 Change: -1.31
Read more →Open: 261.7 Close: 262.51 Change: 0.81
Read more →Open: 257.52 Close: 258.83 Change: 1.32
Read more →Open: 236.48 Close: 234.15 Change: -2.33
Read more →Open: 227.79 Close: 232.57 Change: 4.78
Read more →Open: 225.85 Close: 227.07 Change: 1.22
Read more →Open: 224.16 Close: 222.61 Change: -1.55
Read more →Open: 227.31 Close: 229.04 Change: 1.73
Read more →Open: 229.03 Close: 228.77 Change: -0.26
Read more →Open: 223.08 Close: 221.22 Change: -1.86
Read more →Open: 213.75 Close: 218.07 Change: 4.32
Read more →Open: 220.1 Close: 217.46 Change: -2.64
Read more →Open: 224.21 Close: 225.29 Change: 1.08
Read more →Open: 224.44 Close: 223.42 Change: -1.02
Read more →Open: 224.44 Close: 224.06 Change: -0.38
Read more →Open: 226.02 Close: 225.02 Change: -1.0
Read more →Open: 238.08 Close: 235.97 Change: -2.11
Read more →Open: 236.82 Close: 239.74 Change: 2.92
Read more →